A FOUR WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 2A STUDY OF VARENICLINE TARTRATE (CP-526,555) IN THE TREATMENT OF POST-HERPETIC NEURALGIA

Update Il y a 5 ans
Reference: EUCTR2008-002208-24

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

1.To evaluate the analgesic efficacy of varenicline versus placebo in patients with postherpetic neuralgia (PHN) 2.To evaluate the safety and tolerability of varenicline versus placebo in patients with postherpetic neuralgia. 3.To characterize the pharmacokinetics of varenicline in patients with post-herpetic neuralgia.


Inclusion criteria

  • Post-Herpetic Neuralgia

Links